| Oct 3 |
Volition hosts NETs in sepsis management symposium at ESICM Lives 2024
|
| Sep 16 |
Life Sciences Virtual Investor Forum Agenda Announced for September 19th
|
| Aug 15 |
VolitionRx Limited (VNRX) Q2 2024 Earnings Call Transcript
|
| Aug 15 |
VolitionRX reports Q2 results
|
| Aug 14 |
VolitionRX: Q2 Earnings Snapshot
|
| Aug 14 |
VolitionRx Limited Announces Second Quarter 2024 Financial Results and Business Update
|
| Aug 14 |
VolitionRX Q2 2024 Earnings Preview
|
| Aug 6 |
VolitionRx Limited Schedules Second Quarter 2024 Earnings Conference Call and Business Update
|
| Jul 9 |
Volition appoints PharmaVentures for Capture PCR™ and oncology portfolio licensing
|
| Jun 27 |
VolitionRx Limited Issues Mid-Year Review Ahead of 2024 Annual Meeting
|
